Gadolinium (Gd)-based contrast agents are extensively used for magnetic resonance imaging (MRI). Liposomes are potential nanocarrier-based biocompatible platforms for development of new generations of MRI diagnostics. Liposomes with Gd-complexes (Gd-lip) co-encapsulated with thrombolytic agents can serve both for imaging and treatment of various pathological states including stroke. In this study, we evaluated nanosafety of Gd-lip containing PE-DTPA chelating Gd+3 prepared by lipid film hydration method. We detected no cytotoxicity of Gd-lip in human liver cells including cancer HepG2, progenitor (non-differentiated) HepaRG, and differentiated HepaRG cells. Furthermore, no potential side effects of Gd-lip were found using a complex system including general biomarkers of toxicity, such as induction of early response genes, oxidative, heat shock and endoplasmic reticulum stress, DNA damage responses, induction of xenobiotic metabolizing enzymes, and changes in sphingolipid metabolism in differentiated HepaRG. Moreover, Gd-lip did not show pro-inflammatory effects, as assessed in an assay based on activation of inflammasome NLRP3 in a model of human macrophages, and release of eicosanoids from HepaRG cells. In conclusion, this in vitro study indicates potential in vivo safety of Gd-lip with respect to hepatotoxicity and immunopathology caused by inflammation.

Central European Institute of Technology CEITEC Structural Virology Masaryk University Brno Czech Republic

Faculty of Chemistry Technical University Brno Czech Republic

International Clinical Research Centre St Anne's University Hospital Brno Brno Czech Republic Neurology Department St Anne's University Hospital and Masaryk University Brno Czech Republic

Malvern Instruments Great Malvern UK

Regional Centre of Advanced Technologies and Materials Palacký University Olomouc Czech Republic

Veterinary Research Institute Brno Czech Republic

Veterinary Research Institute Brno Czech Republic Department of Immunology Faculty of Medicine and Dentistry Palacký University Olomouc Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc20028378

003      

CZ-PrNML

005      

20221209084736.0

007      

ta

008      

210105s2020 xxk f 000 0|eng||

009      

AR

024    7_

$a 10.1038/s41598-020-60284-z $2 doi

035    __

$a (PubMed)32179785

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Šimečková, Pavlína $u Veterinary Research Institute, Brno, Czech Republic.

245    10

$a Gadolinium labelled nanoliposomes as the platform for MRI theranostics: in vitro safety study in liver cells and macrophages / $c P. Šimečková, F. Hubatka, J. Kotouček, P. Turánek Knötigová, J. Mašek, J. Slavík, O. Kováč, J. Neča, P. Kulich, D. Hrebík, J. Stráská, K. Pěnčíková, J. Procházková, P. Diviš, S. Macaulay, R. Mikulík, M. Raška, M. Machala, J. Turánek,

520    9_

$a Gadolinium (Gd)-based contrast agents are extensively used for magnetic resonance imaging (MRI). Liposomes are potential nanocarrier-based biocompatible platforms for development of new generations of MRI diagnostics. Liposomes with Gd-complexes (Gd-lip) co-encapsulated with thrombolytic agents can serve both for imaging and treatment of various pathological states including stroke. In this study, we evaluated nanosafety of Gd-lip containing PE-DTPA chelating Gd+3 prepared by lipid film hydration method. We detected no cytotoxicity of Gd-lip in human liver cells including cancer HepG2, progenitor (non-differentiated) HepaRG, and differentiated HepaRG cells. Furthermore, no potential side effects of Gd-lip were found using a complex system including general biomarkers of toxicity, such as induction of early response genes, oxidative, heat shock and endoplasmic reticulum stress, DNA damage responses, induction of xenobiotic metabolizing enzymes, and changes in sphingolipid metabolism in differentiated HepaRG. Moreover, Gd-lip did not show pro-inflammatory effects, as assessed in an assay based on activation of inflammasome NLRP3 in a model of human macrophages, and release of eicosanoids from HepaRG cells. In conclusion, this in vitro study indicates potential in vivo safety of Gd-lip with respect to hepatotoxicity and immunopathology caused by inflammation.

650    _2

$a kultivované buňky $7 D002478

650    12

$a kontrastní látky $7 D003287

650    12

$a nosiče léků $7 D004337

650    _2

$a fibrinolytika $7 D005343

650    12

$a diethylentriaminpentaacetát gadolinia $x škodlivé účinky $x toxicita $7 D019786

650    _2

$a hepatocyty $x účinky léků $7 D022781

650    _2

$a lidé $7 D006801

650    _2

$a inflamasomy $7 D058847

650    12

$a liposomy $7 D008081

650    _2

$a makrofágy $x účinky léků $7 D008264

650    12

$a magnetická rezonanční tomografie $7 D008279

650    _2

$a protein NLRP3 $7 D000071199

650    _2

$a nanočástice $7 D053758

650    12

$a fosfatidylethanolaminy $x škodlivé účinky $x toxicita $7 D010714

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Hubatka, František $u Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Kotouček, Jan $u Veterinary Research Institute, Brno, Czech Republic. $7 xx0279654

700    1_

$a Turánek Knötigová, Pavlína $u Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Mašek, Josef $u Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Slavík, Josef $u Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Kováč, Ondrej $u Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Neča, Jiří $u Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Kulich, Pavel $u Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Hrebík, Dominik $u Central European Institute of Technology CEITEC, Structural Virology, Masaryk University, Brno, Czech Republic.

700    1_

$a Stráská, Jana $u Regional Centre of Advanced Technologies and Materials, Palacký University, Olomouc, Czech Republic.

700    1_

$a Pěnčíková, Kateřina $u Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Procházková, Jiřina $u Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Diviš, Pavel $u Faculty of Chemistry, Technical University, Brno, Czech Republic.

700    1_

$a Macaulay, Stuart $u Malvern Instruments, Great Malvern, UK.

700    1_

$a Mikulík, Robert $u International Clinical Research Centre, St. Anne's University Hospital Brno, Brno, Czech Republic. Neurology Department, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic.

700    1_

$a Raška, Milan $u Veterinary Research Institute, Brno, Czech Republic. Department of Immunology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.

700    1_

$a Machala, Miroslav $u Veterinary Research Institute, Brno, Czech Republic. machala@vri.cz.

700    1_

$a Turánek, Jaroslav $u Veterinary Research Institute, Brno, Czech Republic. turanek@vri.cz.

773    0_

$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 10, č. 1 (2020), s. 4780

856    41

$u https://pubmed.ncbi.nlm.nih.gov/32179785 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20210105 $b ABA008

991    __

$a 20221209084728 $b ABA008

999    __

$a ok $b bmc $g 1608713 $s 1119558

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2020 $b 10 $c 1 $d 4780 $e 20200316 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195

GRA    __

$a NV16-30299A $p MZ0

LZP    __

$a Pubmed-20210105